Dietary supplement for energy and reduced appetite containing the β-agonist isopropyloctopamine leads to heart problems and hospitalisations

In 2013 the Dutch authorities issued a warning against a dietary supplement that was linked to 11 reported adverse reactions, including heart problems and in one case even a cardiac arrest. In the UK a 20-year-old woman, said to have overdosed on this supplement, died. Since according to the label the product was a herbal mixture, initial LC-MS/MS analysis focused on the detection of plant toxins. Yohimbe alkaloids, which are not allowed to be present in herbal preparations according to Dutch legislation, were found at relatively high levels (400–900 mg kg^–1). However, their presence did not explain the adverse health effects reported. Based on these effects the supplement was screened for the presence of a β-agonist, using three different biosensor assays, i.e. the validated competitive radioligand β2-adrenergic receptor binding assay, a validated β-agonists ELISA and a newly developed multiplex microsphere (bead)-based β-agonist assay with imaging detection (MAGPIX^®). The high responses obtained in these three biosensors suggested strongly the presence of a β-agonist. Inspection of the label indicated the presence of N-isopropyloctopamine. A pure standard of this compound was bought and shown to have a strong activity in the three biosensor assays. Analysis by LC-full-scan high-resolution MS confirmed the presence of this ‘unknown known’ β3-agonist N-isopropyloctopamine, reported to lead to heart problems at high doses. A confirmatory quantitative analysis revealed that one dose of the preparation resulted in an intake of 40–60 mg, which is within the therapeutic range of this compound. The case shows the strength of combining bioassays with chemical analytical techniques for identification of illegal pharmacologically active substances in food supplements.     

Partial coalescence as a tool to control sensory perception of emulsions

This study evaluates the role of partial coalescence of whey protein-stabilized emulsions on sensory perception. The selection of fats was restricted to vegetable fats that are essentially melted at oral temperatures. The sensitivity to partial coalescence was controlled by a variation in the fat melting curve and by addition of unsaturated monoglyceride. Most fat-related sensory attributes appear to be well-correlated to an increase in viscosity and coalescence in the mouth due to partial coalescence. Moreover, it was found that in-mouth aeration induces extra coalescence, which increases the perception of fat-related sensory attributes significantly.     

Atomic force microscopy study of the antimicrobial activity of aqueous garlic versus ampicillin against Escherichia coli and Staphylococcus aureus

BACKGROUND: In this study the effects of ampicillin and aqueous garlic extract on Escherichia coli (ATCC 9637) and Staphylococcus aureus (ATCC 25923) were compared. Atomic force microscopy (AFM) was used to study the possible mechanisms of membrane disruption. RESULTS: Ampicillin disrupted the cell membrane of E. coli, inducing pores and cell leakage. Aqueous garlic extract also induced leakage from the cell membrane in E. coli, but no pores were observed. The trend in Young's modulus for E. coli was E_native ≈ E_age > E_amp. In contrast, S. aureus incubated with low ampicillin (≤50µg mL^?1) and garlic (≤50 mg mL^?1) concentrations showed no significant changes in surface morphology compared with the untreated bacterium. The trend in Young's modulus for S. aureus was E_native ≈ E_age ≈ E_amp. CONCLUSION: The trend E_native ≈ E_age for E. coli and S. aureus supports the hypothesis that the compounds in garlic show intracellular activity. This proof‐of‐concept study of the aqueous crude isolate of garlic points to the feasibility of further AFM investigations to compare the antimicrobial properties of various pure thiosulfinate isolates found in garlic. Copyright © 2009 Society of Chemical Industry     

Critical Success Factors for New Product Development in Biotechnology Companies

The development of new products has become increasingly critical for the competitiveness of companies, due to increased diversity and variety of products, the reduction of product life cycles, and, primarily, globalization of markets. Thus, the identification and prioritization of critical success factors for developing new products is important, particularly for the high degree of risk and uncertainty involved. The main objective of this article is the identification and prioritization of critical success factors in new product development projects in biotechnology companies in the state of Minas Gerais, Brazil. The research method used was a survey questionnaire, which was sent to a sample of 31 biotechnology companies in Minas Gerais state. The principal findings of this research are that interpersonal skills/relationships of the project leader and technical skills are the most critical factors for successful new product development in this industry. The implications for the biotechnology industry in general, as well as for those responsible for managing new product development, are discussed.     

Treating intimate partner violence among substance-abusing dyads: The effect of couples therapy.

This study examined whether participation in couples therapy, compared with individual therapy, had a differential effect on the day-to-day relationship between substance use and occurrences of intimate partner violence (IPV) among married or cohabiting substance-abusing men. Patients (N = 207) were randomly assigned to either partner-involved behavioral couples therapy (BCT; included non-substance-abusing female partners in conjoint sessions) or individual-based treatment (IBT; male partners only). Couples in BCT reported lower levels of IPV and substance use at a 12-month posttreatment follow-up compared with couples with male partners in IBT. Moreover, treatment assignment was a significant moderator of the day-to-day relationship between substance use and IPV. Likelihood of nonsevere and severe male-to-female partner violence on days of male partners’ substance use was lower among couples who received BCT compared with IBT. These findings indicate couples therapy may play an important role in the treatment of IPV among substance-abusing couples. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Review of Comprendre et soigner la crise suicidaire.

Reviews the book, Comprendre et soigner la crise suicidaire by Laurent Morasz et Fran?ois Danet (2008).This work examines a psychodynamic theoretical approach focused on the suicide crisis clinic and the “caregiver/cared for” relationship by illustrating different clinical examples representing individuals at various stages of the suicide process. The value and strength of this book lie in the rich and interesting clinical experience it brings forward; there is no attempt to distinguish between “objective” and “more subjective psychodynamic” approaches. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Assessment of bottom-up sectoral and regional mitigation potentials

The greenhouse gas mitigation potential of different economic sectors in three world regions are estimated using a bottom-up approach. These estimates provide updates of the numbers reported in the Fourth Assessment Report of the Intergovernmental Panel on Climate Change (IPCC AR4). This study is part of a larger project aimed at comparing greenhouse gas mitigation potentials from bottom-up and top-down approaches. The sectors included in the analysis are energy supply, transport, industry and the residential and service sector. The mitigation potentials range from 11 to 15 GtCO₂eq. This is 26–38% of the baseline in 2030 and 47–68% relative to the year 2000. Potential savings are estimated for different cost levels. The total potential at negative costs is estimated at 5–8% relative to the baseline, with the largest share in the residential and service sector and the highest reduction percentage for the transport and industry sectors. These (negative) costs include investment, operation and maintenance and fuel costs and revenues at moderate discount rates of 3–10%. At costs below 100 US$/tCO₂, the largest potential reductions in absolute terms are estimated in the energy supply sector, while the transport sector has the lowest reduction potential.